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The Nuclear Factor I (NFI) family of evolutionarily conserved
transcription factors is widely expressed during develop-
ment and in adulthood, in mammals but has mainly been
studied in respect to brain development, where it is
intimately associated with glial function [1,2]. The family
consists of four members, NFIA, NFIB, NFIC and NFIX, each
having multiple splice variants [3]. NFI proteins can directly
bind to the promoter and regulate the transcription activity
of glial fibrillar acidic protein (GFAP), a marker of glial cells
[4]. Different members of the family have been shown to
have a variety of roles in neural development but taken
together, loss-of-function studies of NFI members in mice
reveal a common theme - a lack of development (agenesis)
of the corpus callosum, the large tract of nerve fibers inter-
connecting the left and right hemispheres. The main feature
of corpus callosum agenesis is an inability to perform tasks
where a matching of visual patterns is required, for example
face processing, which in turn results in social difficulties. In
mild cases intelligence is mainly unaffected but low muscle
tone and motor coordination are affected. In severe cases
intellectual retardation, hydrocephalus, seizures and
spasticity might be involved. The effect of a mutation varies
from partial callosal agenesis (in the case of loss of function
of NFIX) to severe agenesis (with loss of function of NFIB
having a greater effect than loss of NFIA, as described later).
Less is known so far about the actions of the NFIX gene than
about the other members of the family. One known
property of NFIX is the regulation of expression of astrocyte-
specific α1-antichymotrypsin [5]. To determine the effects of
loss of function of NFIX, two groups have recently described
knockouts of the NFIX gene [6,7]. Their results turned out
to be surprisingly different. The first knockout was reported
by a team at the University of Freiburg (Driller et al. [6])
while the second was generated by a group from the
University of New York at Buffalo and described in BMC
Developmental Biology (Campbell  et al. [7]). Here, we
briefly review some of the possible reasons for such
discrepancies. For simplicity, we will call the mutant strain
generated in Freiburg ‘X-Freiburg’ and the one generated in
New York ‘X-NY’. Animals of the X-Freiburg strain suffered
from hydrocephalus, partial agenesis of the corpus callo-
sum, and spinal deformities that were due to a delay in
ossification of vertebral bodies and progressive degenera-
tion of intervertebral discs. Femoral defects were also
noticed and animals usually died at around postnatal day
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A previous knockout of the transcription factor gene nuclear factor IX (NFIX) in mice
produced impaired development of the corpus callosum and severe skeletal defects. A recent
paper in BMC Developmental Biology reports an apparently similar NFIX knockout that
produced marked differences in phenotype, raising intriguing general questions about the
possible causes of such differences in mouse knockouts.
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suffer from such severe impairments. Callosal agenesis as
seen in the X-Freiburg strain was not noted in X-NY NFIX-/-
animals. The cingulate cortex and the entire brain are
expanded along the dorsal-ventral axis, hippocampus forma-
tion is aberrant, and overabundant Pax6- and doublecortin-
positive cells are found in the lateral ventricles of X-NY mice.
When the X-NY mice were fed with a soft dough chow they
showed a lag in weight gain compared to non-mutant
animals, but after P20 the growth rate increased and a few
of the animals survived to adulthood. Skeletal deformities
observed by Driller et al. and absent in the animals reported
by Campbell et al. can be attributed to the severe mal-
nutrition, which was relieved by Campbell et al. by the
change in diet. Another possibility is that brain develop-
ment abnormalities result in reduced appetite, leading again
to skeletal defects.
R Re ec co on nc ci il li in ng g   t th he e   d di if ff fe er re en nc ce es s
How can the discrepancies reported between the two NFIX-/-
strains be reconciled? Among various possible explanations,
one could be an alteration of neighboring gene expression.
A case in point is the sequential generation of several prion
protein (PrP) knockout strains that showed profoundly
different phenotypes. Only later was this variation proved
to be due to the unintentional activation of another gene in
the vicinity of the PrP gene, later named Doppel [8], and
which was shown to be neurotoxic.
Both reports of the NFIX knockouts [6,7] describe the
deletion of the second exon, which is uniformly present in
all splice variants and carries the dimerization and DNA-
binding domains (Figure 1). In both cases the targeting
constructs were based on a λ phage library derived from the
mouse strain 129/Sv, and transgenic animals carrying a
single knockout allele were backcrossed to C57BL/6 mice
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For simplicity the same structure is drawn for all four NFI genes. ( (a a) ) The organization of the NFI genes. They can all use an alternative exon 1, here
denoted as a single box labeled 1a/1b. The DNA-binding and dimerization domains are located in exon 2. ( (b b) )   In general, two approaches are used for
knockouts of these genes. The first relies on complete deletion of the second exon (including 5’ and 3’ splice acceptor sites of proximal introns), as
shown here in the X-NY knockout. The second strategy is to insert LacZ (or a LacZ-neo hybrid or PGK-neo hybrid) in-frame into the second exon,
leading to production of a fusion protein composed of a few amino acids derived from exons 1 and 2 of the NFI and LacZ genes. In all cases an
alternative splice variant joining the first and the third exon of the NFI gene will be formed. The third exon is not in frame with the first, and so
premature termination of translation will occur. Whether a peptide produced from the joining of exons 1 and 3 has any physiological function was
never analyzed, but judging from the very different phenotypes of the different knockout strains it seems rather unlikely. The NFIB constructs are
reported in [15,16], the NFIA knockout in [17] and the NFIC knockout in [18].
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(b)for several generations. However, each research group used
a slightly different embryonic stem (ES) cell line for making
the mutation. In the case of the X-NY strain the targeting
vector was electroporated into J1 ES cells, which are derived
from the 129S4/SvJae strain and backcrossed to the C57BL/6
mouse strain for two to five generations. The X-Freiburg
targeting construct was electroporated into CJ7 ES cells,
which originate from the 129S1/Sv strain (129S1/Sv-
p+Tyr+KitlSl-J) and transgenic animals were backcrossed to
C57BL/6. Driller et al. [6] do not specify the number of
backcrossings to C57BL/6, which raises the possibility that
their knockout strains, although apparently congenic with
those of Campbell et al., contain a substantial segment of
ES-cell-derived chromosome still flanking the knockout
allele - a ‘congenic footprint’.
In a study of congenic knockouts at another gene,
Schalkwyk  et al. [9] found that at least 10 genes across
40 Mb around the targeted locus show differences in
expression in the different knockout strains, due to the
congenic footprint effect. Genome-wide analysis of gene
expression in different tissues of knockout animals by
microarray profiling also indicates that a significant pro-
portion of changes are found in the proximity of the
targeted gene [10,11]. This little excursion into the theory of
induced mutation experiments does not seem so trivial in
the light of several studies describing corpus callosum
defects in the 129/Sv strain itself [12,13], which vary
between 129 substrains studied [14]. Callosal agenesis is
one of the phenotypic features ascribed to the X-Freiburg
strain, while at the same time complete callosal agenesis
was not seen in X-NY strain. The locus (or loci) responsible
for callosal agenesis in the 129/Sv strain is not characterized
and it is not unreasonable to speculate that such a region
might be present in the proximity of NFIX in the X-Freiburg
strain, whereas in the X-NY strain this locus had been
removed by outbreeding.
Another possible source of variation emanates from the
targeting strategy used. Campbell et al. completely deleted
the second exon along with proximal parts of neighboring
introns, whereas Driller et al. replaced the second exon with
a coding sequence of the LacZ gene fused to a coding
sequence of NFIX (Figure 1b). In this regard, a comparison
of all the available NFI gene knockouts is perhaps more
informative (Figure 1b). An intriguing feature that emerges
from this comparison is that mice in which the 3’ splice
acceptor of the first intron is removed somehow have a
milder phenotype. Without further experimental evidence it
is difficult to explain this observation, which could be
purely coincidental. Formation of an alternatively spliced
gene variant (which was not looked for), as with the
activation of Doppel [8], is one possibility. Alternatively, the
fusion of the first few amino acids of NFIX (or NFIB) to
LacZ might lead to a toxic gain-of-function protein. The
peptide in question is quite short but even so could endow
the fusion protein with toxic properties. This hypothesis is
rather easy to test by overexpressing recombinant NFIXexon1-
LacZ protein in glial or neuronal cells.
A full explanation of these intriguing phenotypes will
require experimental testing and a proper analysis of the
ideas put forward here, as well as other possibilities.
Thorough analysis of all available knockouts might reveal
surprising new functions of NFI proteins and further
enhance our understanding of their biological functions.
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